Mark Peggie Obituary, Death – On January 17, 2023, at the age of 54, Mark Peggie, who had been the Head of the Cloning Team at the MRC PPU for a number of years, suddenly away unexpectedly. He had worked in this capacity for a lot of years. We are passing on the news of his passing with the utmost sadness that we feel. Mark earned his Bachelor of Science degree from the University of Alberta, where he majored in Molecular Biology and graduated with honors. Mark was instrumental in developing the DNA cloning service so that it could offer assistance to other departments within the School of Life Sciences.
In this capacity, Mark played a significant role. During the same time period, he was also successful in completing the requirements for the Master of Business Administration degree. Later on, Mark and Rachel expanded the DNA cloning service so that it could assist academic institutions and enterprises located in different countries all over the world. This was done as part of the Reagents and Services laboratory that was located at the MRC PPU. Two measures that can be used to evaluate the significant contribution that Mark has made are the 12,000 clones that he created and the inclusion of his name on an innumerable number of procedures, PCR machine programs, and other reagents and publications.
Both of these measures can be used to determine that Mark has made a significant contribution. erdeen, where she also received her PhD degree, prior to moving to Dundee for postdoctoral studies in the field of biological sciences. erdeen is the city in where she currently resides. Her academic career began in Aberdeen. After that, he spent the next three years working in the lab of Michael Stark at Dundee’s Division of Gene Regulation and Expression on projects pertaining to chromosome stability and the nuclear localization of protein phosphatase 1 (PP1) in yeast as a model system [1]. These projects were conducted using yeast as a test organism.
During this period, he was working closely with Michael Stark, who served as his mentor. Mark joined the MRC Patient Participation Unit (PPU) in the year 2001. Initially, he worked closely with Maria Deak to provide help to the research teams working on DNA cloning within the Unit. These teams were led by the Unit. A year later, the cloning team was expanded so that they could also provide support for the Division of Signal Transduction Therapy (DSTT), which was a collaboration between the Unit and six of the largest pharmaceutical corporations in the world. DSTT was an acronym that stood for “Division of Signal Transduction Therapy.” Rachel Toth and Nicola Wood joined the DNA cloning team around this time, which brings the total number of people on the team to four.